Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 8730-8731 [2019-04404]
Download as PDF
8730
Federal Register / Vol. 84, No. 47 / Monday, March 11, 2019 / Notices
have been updated to reflect the
Department’s 2019 poverty guidelines as
published in 84 FR 1167 (February 1,
2019).
LOW-INCOME LEVELS BASED ON THE
2019 POVERTY GUIDELINES FOR THE
48 CONTIGUOUS STATES AND THE
DISTRICT OF COLUMBIA
Persons in family/household *
1
2
3
4
5
6
7
8
Puerto Rico or other outlying
jurisdictions. Puerto Rico and other
outlying jurisdictions shall use income
guidelines for the 48 Contiguous States
and the District of Columbia.
Dated: March 4, 2019.
George Sigounas,
Administrator.
[FR Doc. 2019–04407 Filed 3–8–19; 8:45 am]
BILLING CODE 4165–15–P
Income Level **
......................................
......................................
......................................
......................................
......................................
......................................
......................................
......................................
$24,980
33,820
42,660
51,500
60,340
69,180
78,020
86,860
For families with more than 8 persons, add
$8,840 for each additional person.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice.
AGENCY:
LOW-INCOME LEVELS BASED ON THE
2019 POVERTY GUIDELINES FOR SUMMARY: As stipulated by the Federal
ALASKA
Advisory Committee Act, the
Persons in family/household *
1
2
3
4
5
6
7
8
Income Level **
......................................
......................................
......................................
......................................
......................................
......................................
......................................
......................................
$31,200
42,260
53,320
64,380
75,440
86,500
97,560
108,620
For families with more than 8 persons, add
$11,060 for each additional person.
LOW-INCOME LEVELS BASED ON THE
2019 POVERTY GUIDELINES FOR HAWAII
Persons in family/household *
1
2
3
4
5
6
7
8
Income Level **
......................................
......................................
......................................
......................................
......................................
......................................
......................................
......................................
$28,760
38,920
49,080
59,240
69,400
79,560
89,720
99,880
amozie on DSK9F9SC42PROD with NOTICES
For families with more than 8 persons, add
$10,160 for each additional person.
* Includes only dependents listed on federal
income tax forms.
** Adjusted gross income for calendar year
2018.
Separate poverty guidelines figures
for Alaska and Hawaii reflect Office of
Economic Opportunity administrative
practice beginning in the 1966–1970
period since the U.S. Census Bureau
poverty thresholds do not have separate
figures for Alaska and Hawaii. The
poverty guidelines are not defined for
VerDate Sep<11>2014
18:41 Mar 08, 2019
Jkt 247001
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
on April 8, 2019, for the Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria (Advisory
Council). The meeting will be open to
the public via teleconference. Preregistration is required for members of
the public who wish to attend the
meeting via teleconference. Individuals
who wish to send in their public
comments should send an email to
CARB@hhs.gov. Registration
information is available on the website
https://www.hhs.gov/ash/carb/ and must
be completed by April 2, 2019.
Additional information about registering
for the meeting and providing public
comments can be obtained at https://
www.hhs.gov/ash/carb/ on the Meetings
page.
DATES: The meeting is scheduled to be
held on April 8, 2019, from 12:00 p.m.
to 2:00 p.m. ET (times are tentative and
subject to change). The confirmed times
and agenda items for the meeting will be
posted on the website for the Advisory
Council at https://www.hhs.gov/ash/
carb/ when this information becomes
available. Pre-registration for attending
the meeting is required to be completed
no later than April 2, 2019.
ADDRESSES: Instructions regarding
attending this meeting virtually will be
posted one week prior to the meeting at:
https://www.hhs.gov/ash/carb/.
FOR FURTHER INFORMATION CONTACT:
Jomana Musmar, Designated Federal
Officer, Presidential Advisory Council
on Combating Antibiotic-Resistant
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Bacteria, Office of the Assistant
Secretary for Health, U.S. Department of
Health and Human Services, Room
L133, Switzer Building, 330 C. St. SW,
Washington, DC 20201. Phone: (202)
690–5566; email: CARB@hhs.gov.
SUPPLEMENTARY INFORMATION: Under
Executive Order 13676, dated
September 18, 2014, authority was given
to the Secretary of HHS to establish the
Advisory Council, in consultation with
the Secretaries of Defense and
Agriculture. Activities of the Advisory
Council are governed by the provisions
of Public Law 92–463, as amended (5
U.S.C. App.), which sets forth standards
for the formation and use of federal
advisory committees.
The Advisory Council will provide
advice, information, and
recommendations to the Secretary of
HHS regarding programs and policies
intended to support and evaluate the
implementation of Executive Order
13676, including the National Strategy
for Combating Antibiotic-Resistant
Bacteria and the National Action Plan
for Combating Antibiotic-Resistant
Bacteria. The Advisory Council shall
function solely for advisory purposes.
In carrying out its mission, the
Advisory Council will provide advice,
information, and recommendations to
the Secretary regarding programs and
policies intended to preserve the
effectiveness of antibiotics by
optimizing their use; advance research
to develop improved methods for
combating antibiotic resistance and
conducting antibiotic stewardship;
strengthen surveillance of antibioticresistant bacterial infections; prevent
the transmission of antibiotic-resistant
bacterial infections; advance the
development of rapid point-of-care and
agricultural diagnostics; further research
on new treatments for bacterial
infections; develop alternatives to
antibiotics for agricultural purposes;
maximize the dissemination of up-todate information on the appropriate and
proper use of antibiotics to the general
public and human and animal
healthcare providers; and improve
international coordination of efforts to
combat antibiotic resistance.
The public meeting will be dedicated
to deliberation and vote of the report
with recommendation from the
Immediate Action Subcommittee of the
Advisory Council. The meeting agenda
will be posted on the Advisory Council
website at https://www.hhs.gov/ash/
carb/ when it has been finalized. All
agenda items are tentative and subject to
change.
Instructions regarding attending this
meeting virtually will be posted one
E:\FR\FM\11MRN1.SGM
11MRN1
8731
Federal Register / Vol. 84, No. 47 / Monday, March 11, 2019 / Notices
week prior to the meeting at: https://
www.hhs.gov/ash/carb/.
Members of the public will have the
opportunity to provide comments prior
to the Advisory Council meeting by
emailing CARB@hhs.gov. Public
comments should be sent in by
midnight April 2, 2019, and should be
limited to no more than one page. All
public comments received prior to April
2, 2019, will be provided to Advisory
Council members and will be
acknowledged during the public
teleconference.
Dated: February 26, 2019.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Committee Manager.
[FR Doc. 2019–04404 Filed 3–8–19; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier 4040–0002]
Agency Information Collection
Request. 60-Day Public Comment
Request
AGENCY:
Office of the Secretary, HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before May 10, 2019.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 4040–0002–60D
and project title for reference., to
Sherrette.funn@hhs.gov, or call the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
SUMMARY:
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: The SF–424
Mandatory Form.
Type of Collection: Reinstatement
without change.
OMB No. 4040–0002.
Abstract: The SF–424 Mandatory
Form provides the Federal grant-making
agencies an alternative to the Standard
Form 424 data set and form. Agencies
may use the SF–424 Mandatory Form
for grant programs not required to
collect all the data that is required on
the SF–424 core data set and form.
Type of respondent: The SF–424
Mandatory form is used by
organizations to apply for Federal
financial assistance in the form of
grants. These forms are submitted to the
Federal grant-making agencies for
evaluation and review.
ANNUALIZED BURDEN HOUR TABLE
SF–424 Mandatory ...........................
Grant applicants ...............................
5761
1
1
5761
Total ...........................................
...........................................................
5761
1
1
5761
Tissue Safety and Availability
(ACBTSA) will hold a meeting. The
meeting will be open to the public.
BILLING CODE 4151–AE–P
The meeting will take place
Monday, April 15, 2019, from 8:00 a.m.–
4:30 p.m. and Tuesday, April 16, 2019,
from 8:30 a.m.–4:00 p.m.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ADDRESSES:
DATES:
[FR Doc. 2019–04288 Filed 3–8–19; 8:45 am]
Meeting of the Advisory Committee on
Blood and Tissue Safety and
Availability
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice.
AGENCY:
amozie on DSK9F9SC42PROD with NOTICES
Average
burden per
response
Respondents
(if necessary)
Dated: March 5, 2019.
Terry Clark,
Assistant Information Collection Clearance
Officer.
Number of
respondents
Number of
responses per
respondents
Forms
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Advisory Committee on Blood and
SUMMARY:
VerDate Sep<11>2014
18:41 Mar 08, 2019
Jkt 247001
U.S. Department of Health &
Human Services, Hubert H. Humphrey
Building, (Conference Room 800), 200
Independence Ave. SW, Washington,
DC 20201.
Mr.
James Berger, Designated Federal Officer
for the ACBTSA, Senior Advisor for
Blood and Tissue Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services, Mary E. Switzer Building, 330
C Street SW, Suite L100, Washington,
DC 20024. Phone: (202) 795–7697; Fax:
(202) 691–2102; Email: ACBTSA@
hhs.gov.
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Total
burden hours
The
ACBTSA provides advice to the
Secretary through the Assistant
Secretary for Health. The Committee
advises on a range of policy issues to
include: (1) Identification of public
health issues through surveillance of
blood and tissue safety issues with
national survey and data tools; (2)
identification of public health issues
that affect availability of blood, blood
products, and tissues; (3) broad public
health, ethical, and legal issues related
to the safety of blood, blood products,
and tissues; (4) the impact of various
economic factors (e.g., product cost and
supply) on safety and availability of
blood, blood products, and tissues; (5)
risk communications related to blood
transfusion and tissue transplantation;
and (6) identification of infectious
disease transmission issues for blood,
organs, blood stem cells and tissues.
The Committee has met regularly since
its establishment in 1997.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\11MRN1.SGM
11MRN1
Agencies
[Federal Register Volume 84, Number 47 (Monday, March 11, 2019)]
[Notices]
[Pages 8730-8731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04404]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting is scheduled to be held on April 8, 2019, for the
Presidential Advisory Council on Combating Antibiotic-Resistant
Bacteria (Advisory Council). The meeting will be open to the public via
teleconference. Pre-registration is required for members of the public
who wish to attend the meeting via teleconference. Individuals who wish
to send in their public comments should send an email to CARB@hhs.gov.
Registration information is available on the website https://www.hhs.gov/ash/carb/ and must be completed by April 2, 2019.
Additional information about registering for the meeting and providing
public comments can be obtained at https://www.hhs.gov/ash/carb/ on the
Meetings page.
DATES: The meeting is scheduled to be held on April 8, 2019, from 12:00
p.m. to 2:00 p.m. ET (times are tentative and subject to change). The
confirmed times and agenda items for the meeting will be posted on the
website for the Advisory Council at https://www.hhs.gov/ash/carb/ when
this information becomes available. Pre-registration for attending the
meeting is required to be completed no later than April 2, 2019.
ADDRESSES: Instructions regarding attending this meeting virtually will
be posted one week prior to the meeting at: https://www.hhs.gov/ash/carb/.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Designated Federal
Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room L133, Switzer Building,
330 C. St. SW, Washington, DC 20201. Phone: (202) 690-5566; email:
CARB@hhs.gov.
SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September
18, 2014, authority was given to the Secretary of HHS to establish the
Advisory Council, in consultation with the Secretaries of Defense and
Agriculture. Activities of the Advisory Council are governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets
forth standards for the formation and use of federal advisory
committees.
The Advisory Council will provide advice, information, and
recommendations to the Secretary of HHS regarding programs and policies
intended to support and evaluate the implementation of Executive Order
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating
Antibiotic-Resistant Bacteria. The Advisory Council shall function
solely for advisory purposes.
In carrying out its mission, the Advisory Council will provide
advice, information, and recommendations to the Secretary regarding
programs and policies intended to preserve the effectiveness of
antibiotics by optimizing their use; advance research to develop
improved methods for combating antibiotic resistance and conducting
antibiotic stewardship; strengthen surveillance of antibiotic-resistant
bacterial infections; prevent the transmission of antibiotic-resistant
bacterial infections; advance the development of rapid point-of-care
and agricultural diagnostics; further research on new treatments for
bacterial infections; develop alternatives to antibiotics for
agricultural purposes; maximize the dissemination of up-to-date
information on the appropriate and proper use of antibiotics to the
general public and human and animal healthcare providers; and improve
international coordination of efforts to combat antibiotic resistance.
The public meeting will be dedicated to deliberation and vote of
the report with recommendation from the Immediate Action Subcommittee
of the Advisory Council. The meeting agenda will be posted on the
Advisory Council website at https://www.hhs.gov/ash/carb/ when it has
been finalized. All agenda items are tentative and subject to change.
Instructions regarding attending this meeting virtually will be
posted one
[[Page 8731]]
week prior to the meeting at: https://www.hhs.gov/ash/carb/.
Members of the public will have the opportunity to provide comments
prior to the Advisory Council meeting by emailing CARB@hhs.gov. Public
comments should be sent in by midnight April 2, 2019, and should be
limited to no more than one page. All public comments received prior to
April 2, 2019, will be provided to Advisory Council members and will be
acknowledged during the public teleconference.
Dated: February 26, 2019.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Committee Manager.
[FR Doc. 2019-04404 Filed 3-8-19; 8:45 am]
BILLING CODE 4150-44-P